Liver Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Jul 15, 2003; 9(7): 1455-1459
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1455
Figure 4
Figure 4 The transformed pQE-30-ARL BL21 induced by 0. 05 mM isopropyl-1-thio-β-D-galactopyranoside. Lane 1: BL21 transformed with pQE-30-ARL, no IPTG induced; Lane 2: BL21 transformed with pQE-30-ARL, IPTG induced, ARL-(His)6(35.7 KD) could express; Lane 3: supernatant; Lane 4: pellet; Lane 5: purified ARL-(His)6; Lane 6: mid-range protein molecular weight markers.